For years, we’ve been having the same conversation with patients:

“Doc, you keep talking about autophagy and cellular cleanup. But how do we actually *know* it’s happening when I fast?”

The honest answer was unsatisfying: “Well, we see it beautifully in mice, and the metabolic markers in humans suggest it’s happening, but...”

That ‘but’ just got a lot smaller.

Researchers at Cedars-Sinai just published something we’ve been waiting for in longevity medicine: the first human trial that directly measures autophagic flux during a fasting intervention. Not metabolic proxies. Not assumptions from rodent studies. Actual human autophagy activation.1

Let me explain why this matters.

The Cellular Housekeeping We’ve Been Banking On

Think of autophagy as your cells’ recycling program. Every day, damaged proteins, dysfunctional mitochondria, and cellular debris accumulate like junk in a garage. Autophagy is the process that tags this junk, packages it up, and breaks it down for parts.

When autophagy works well, your cells stay young and efficient. When it declines — which happens with age, overfeeding, and chronic disease — that cellular junk piles up. The result? Inflammation, metabolic dysfunction, and accelerated aging.

We’ve known from elegant animal research that fasting is one of the most powerful autophagy triggers. But measuring it directly in living humans has been, until now, technically nightmarish. Most studies measured indirect markers like ketones or circulating amino acids and said, “Autophagy is *probably* happening.”

Probably doesn’t cut it when you’re asking patients to go five days on 700 calories.

What the Study Actually Showed

The Cedars-Sinai team enrolled 30 adults in a pilot trial using the Fasting Mimicking Diet (FMD) — specifically Prolon, a 5-day protocol that drops calories to around 700-1,100 per day while maintaining specific macronutrient ratios designed to keep you in a fasted metabolic state.

Here’s what made this study different: they used sophisticated biomarkers to measure autophagic flux directly. This isn’t just “ketones went up” or “mTOR went down.” They tracked the actual turnover of cellular components being degraded through autophagy.

The results? Autophagic activity measurably increased during the FMD period. Not in mice. In humans. In a controlled setting with direct measurements.

Bonus findings that anyone who’s done FMD protocols will recognize: participants also showed improvements in weight (average 5.7 lbs), fasting glucose, insulin sensitivity, and ketone production. But those were the supporting cast. The star of this show was autophagy itself.

Study design graphic: 11 participants on ProLon, 10 on a second fasting-mimicking diet and 9 controls, with blood draws across days 0 to 8, an LC3-chloroquine assay measuring autophagic flux, and key findings of lower body weight, fasting glucose and HOMA-IR, higher beta-hydroxybutyrate, and increased autophagic flux at day 6.

Why This Changes the Conversation

I’m not usually one to get excited about pilot studies with 30 people. But this one matters because it validates the mechanistic foundation under an entire category of longevity interventions.

For years, the fasting-for-longevity conversation has rested on three legs: animal data (strong), mechanistic plausibility (strong), and human metabolic improvements (decent). The weakest link was always the question: “But does it actually trigger the cellular repair processes we care about in humans?”

Now we can say yes. Not “probably.” Not “we think so.” Yes.

This doesn’t mean FMD is a magic bullet. The study was small, short-term, and funded by the company that makes Prolon (though conducted by independent academic researchers). We need larger trials, longer follow-up, and head-to-head comparisons with other fasting protocols.

But for the first time, we have human evidence bridging the gap between “this should work” and “this actually does what we think it does at the cellular level.”

Two charts of autophagic flux across visits V1 to V4. Panel A plots the chloroquine-treated to untreated LC3B-II/I ratio for the control, ProLon and FMD2 groups. Panel B plots percent change from baseline, where ProLon rises roughly 100 percent by visit 3 — the only statistically significant change in the study.

The Practical Reality

Here’s what I’m telling patients now: If you’re considering periodic fasting for longevity purposes, this study provides the first direct human evidence supporting the cellular mechanisms we’ve been theorizing about.

The 5-day FMD protocol isn’t easy — my patients (and me personally) report it’s mentally and physically challenging, especially days 2-3. But it’s more doable than water fasting, and now we have human data showing it’s doing what we hoped at the cellular level.

My usual recommendation: try it quarterly if you’re metabolically healthy and looking for a longevity intervention. More often might be appropriate for specific clinical situations, but this isn’t something to do weekly.

How Long Do You Have to Fast for Autophagy? What the Human Data Says

This is the question I get most often, and the honest answer is that the human evidence is thin below multi-day protocols. Mouse data shows autophagy ramping within 24 hours of food withdrawal, but mice burn through glycogen and switch fuels far faster than we do. In people, the metabolic switch to ketones typically takes 12 to 36 hours, and the autophagy signal appears to lag behind it.

ProtocolWhat happens metabolicallyDirect human autophagy evidence
12–16 h time-restricted eatingInsulin falls; ketones rise modestly overnightNone yet — mechanistically plausible, unmeasured
24-hour fastGlycogen largely depleted; ketones climbLimited — small blood-cell marker studies, no flux measurement
48–72 h water fastSustained ketosis; growth signaling (mTOR, IGF-1) downSuggestive — marker changes in blood cells reported in small studies
5-day fasting-mimicking dietFasted-state physiology at 700–1,100 kcal/dayStrongest — this trial: flux roughly doubled by day 5–6

Two practical points follow. First, the signal in this study was strongest at the end of the five days, which matches what patients report: days one and two are the hard part, and the metabolic payoff arrives after the switch. Second, an intermittent 16:8 schedule is a perfectly good tool for weight, insulin and appetite control, but if autophagy is the reason you are doing it, the human evidence does not yet support that claim. I break the timing question down protocol by protocol in How long do you have to fast for autophagy?

Fasting-Mimicking Diet vs. Water Fasting vs. Intermittent Fasting

A fasting-mimicking diet is a five-day, plant-based, low-protein, low-sugar meal kit calibrated so the body reads it as fasting while you still eat. It was designed so that people who cannot or will not water-fast for five days can get the same physiology with less risk of electrolyte problems, muscle loss and abandonment on day two. Water fasting for the same period produces a deeper state but needs medical supervision. Intermittent fasting is a daily eating window; it never reaches the multi-day territory where autophagy has actually been measured in humans.

The Bottom Line

We finally have direct human evidence that fasting-mimicking diets activate autophagy — the cellular cleanup process linked to longevity and disease prevention. This bridges the critical gap between promising animal research and clinical practice. While we need larger and longer studies, this validates the mechanistic foundation of fasting-based longevity protocols.

For My Fellow Physicians

The methodology here is what excites me. They used LC3-II and p62 measurements — the gold standard autophagy markers — in peripheral blood mononuclear cells. Not perfect (tissue-specific autophagy varies), but far better than the indirect markers we’ve relied on.

Key clinical considerations:

- Screen for contraindications: active eating disorders, underweight BMI, pregnancy, Type 1 diabetes

- Monitor electrolytes if patients are on diuretics or have renal disease

- Consider holding metformin, GLP1s or SGLT2i during the FMD period (hypoglycemia risk)

- The autophagy signal appears strongest on days 3-5, which tracks with the metabolic switch timeline

- This was Prolon specifically, but the principles likely apply to other well-designed FMD protocols

Importantly: this doesn’t prove longevity benefits in humans yet. Autophagy activation is mechanistically linked to longevity pathways, but we’re still connecting dots. Clinical endpoints matter.

Closing Question

Now that we have direct human evidence of autophagy activation, does this change your thinking about periodic fasting protocols? And for those who’ve tried FMD — how did your experience match the science?

Frequently asked questions

Does fasting actually activate autophagy in humans?

Yes. A Cedars-Sinai pilot trial published in GeroScience in 2025 was the first to directly measure autophagic flux in humans during fasting, using LC3-II and p62 in blood cells. A 5-day fasting-mimicking diet roughly doubled the autophagy signal by the third study visit. That was the only statistically significant change in the trial.

Does 16:8 intermittent fasting trigger autophagy?

There’s no direct human evidence yet. Autophagy from 12–16 hour time-restricted eating is plausible in theory but hasn’t been measured. The measurable signal in people shows up with multi-day protocols and is strongest around days 3 to 5. A 16:8 schedule is still a good tool for weight, insulin and appetite control.

What is a fasting-mimicking diet?

A fasting-mimicking diet is a five-day, plant-based, low-protein, low-sugar meal kit at roughly 700–1,100 calories a day, calibrated so the body reads it as fasting while you still eat. Compared with a five-day water fast, it carries less risk of electrolyte problems, muscle loss and quitting on day two.

Does fasting-induced autophagy help you live longer?

Not proven yet. The Cedars-Sinai study confirms the mechanism, but nobody has shown that fasting-induced autophagy extends human lifespan or prevents disease. The trial was small, short-term and funded by Prolon’s maker. For metabolically healthy people, Dr. Sorrell typically suggests a fasting-mimicking diet quarterly, not weekly.

References

  1. Espinoza SE, Park S, Connolly G, Qi W, Semwal M, Zhang N, Li Y, Salmon AB, Musi N, Wei M, Hsu W. “Effect of fasting-mimicking diet on markers of autophagy and metabolic health in human subjects.” GeroScience (2025). DOI: 10.1007/s11357-025-02035-4